Tag archive for ‘Food and Drug Administration’
By pharmanewsdaily On Tuesday, January 26th, 2021

US FDA approves Opdivo, Cabometyx combo for advanced renal cell carcinoma

The US Food and Drug Administration (FDA) has approved the combination of Bristol Myers Squibb’ Opdivo (nivolumab) and Exelixis’ Cabometyx (cabozantinib) as a first line therapy for advanced renal cell carcinoma More...

By pharmanewsdaily On Sunday, November 8th, 2020

AstraZeneca gets BRILINTA FDA approval for reducing risk of stroke in acute ischemic stroke or high-risk transient ischemic attack

BRILINTA FDA approval : AstraZeneca has bagged approval for BRILINTA (ticagrelor) from the US  Food and Drug Administration for its use in reducing the risk of stroke in patients having acute ischemic stroke or More...

By pharmanewsdaily On Sunday, June 28th, 2020

Masimo gets FDA clearance for Centroid patient monitoring sensor

Masimo, a US medical device company, has received clearance from the US Food and Drug Administration (FDA) for Centroid, the company’s wearable, wireless patient orientation, activity, and respiration rate More...

By pharmanewsdaily On Thursday, February 20th, 2020

PADCEV, KEYTRUDA combination for advanced bladder cancer gets FDA breakthrough therapy status

PADCEV, KEYTRUDA combination : Astellas Pharma and Seattle Genetics said that the combination of PADCEV (enfortumab vedotin-ejfv) and Merck’s anti-PD-1 therapy KEYTRUDA (pembrolizumab) has been given breakthrough More...

By pharmanewsdaily On Wednesday, January 1st, 2020

LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection

Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus (QFT-Plus automated screening solution) on the latter’s LIAISON platforms for detecting latent More...

By pharmanewsdaily On Monday, August 5th, 2013

Stryker hip lawyers on Recall of Stryker hip implants

What are Stryker Hip Implants? What is Stryker Hip Recall? The Stryker Orthoaedics company announced voluntary recall of the rejuvenate and ABG II modular neck stem devices as they were found to be vulnerable and More...